ARTICLE | Clinical News
Eperzan albiglutide regulatory update
March 11, 2013 7:00 AM UTC
GlaxoSmithKline submitted an MAA to EMA for Eperzan albiglutide to treat Type II diabetes. The pharma submitted an NDA to FDA for the product in January. GSK gained the fusion protein of human albumin...